BinaxNOW^® RSV

The BinaxNOW^® RSV test is one of the easiest tests to run on the market today. Rapid results are available in 15 minutes with no hands-on time. Critical care instructions can be provided to parents prior to the child leaving the paediatrician’s office and valuable information can be obtained prior to hospital admission to help control the spread of RSV infections. Now the focus can be on the results and care of your patients, not running the test.

Intended Use

The BinaxNOW^® RSV test is a rapid immunochromatographic assay for the qualitative detection of respiratory syncytial virus (RSV) fusion protein antigen in nasal wash and nasopharyngeal (NP) swab specimens from symptomatic patients. This test is intended for in vitro diagnostic use to aid in the diagnosis of RSV infections in neonatal and paediatric patients under the age of five. It is recommended that negative test results be confirmed by cell culture.

Product Details

BinaxNOW® RSV

Sample Type:	Nasopharyngeal swab, nasal wash
Time to Result:	15 minutes
Kit Size:	22 or 42 tests
Performance data:	Nasal WashSensitivity/Specificity– 89% / 100%*
	NP SwabSensitivity/Specificity– 93% / 93%
Regulatory:	Cleared for distribution by the FDA and CE marked,
	available in 11 languages

For instructions for use, see package insert

About RSV

Respiratory syncytial virus (RSV) is a common cause of upper and lower respiratory tract infections and the major cause of bronchiolitis and pneumonia in infants and children. Infections and outbreaks due to RSV typically occur yearly in the fall, winter, and spring. While RSV can cause significant respiratory illness in older children and adults, the disease tends to be milder in these populations than in infants and young children.

Rapid identification and diagnosis of RSV has become more important due to the availability of effective antimicrobial therapy. Rapid identification can lead to reductions in hospital stays, antimicrobial use, and the cost of hospital care¹.

For more information about RSV, please see the links below:

• CDC: Respiratory Syncytial Virus Infection
• RSV Protection.com
• RSV and Synagis^® (Palivizumab): Synagis
• eMedicine: Respiratory Syncytial Virus Infection

References

1. Williams KM, Jackson MA, Hamilton M. Rapid diagnostic testing for URIs in children: impact on physician decision making and cost. Infect Med. 2002;19(3):109-111.

*Retrospective data. See package insert for complete performance information.